Recent dips in Corona Virus The director of the Centers for Disease Control and Prevention (CDC) warned Wednesday of signs of a slowdown in cases, hospitalizations and deaths, adding that the country is in a “critical link” in the pandemic.
“We knew this was going to happen as the variables emerged and reached more people in more societies,” Walinsky said, “but we can still reduce their impact.”
The United States is currently seeing an average seven-day average of 66,010 new coronavirus cases, which is a 3.5% increase over the previous week, while deaths are also 2.2% higher than the previous week’s average.
Wallinski said: “Today we are in a critical link in the epidemic, and a lot could turn out in the next few weeks.” “On the one hand, cases in the country are stabilizing at rates on the cusp of their reappearance, and the fast-moving variant B.1.1.7 is moving ready to hijack our success so far. On the other hand, stamina has diminished, fatigue wins, and the meticulous measures we have taken to stop The epidemic is now grossly ignored. “
Walensky’s warning comes as several states move to lift coronavirus restrictions such as mask mandates and restrictions on indoor gatherings. Texas, for example, on Tuesday discarded its mask mandate marking the largest state to do so.
Biden administration, Which announced on Tuesday that the United States will have enough vaccine to vaccinate every adult by May, has reiterated calls from the public to continue using masks regardless of the state’s mandate. Wallinski again asked people to “go deep” and continue to adhere to public health measures in order to “protect the health of the nation and our loved ones.”
“How this is implemented is up to us,” she said. “The next three months will be pivotal.”
Regarding the variables, Dr. Anthony Fauci said that work is underway at the National Institutes of Health in collaboration with vaccine manufacturers to study several ways to enhance the effectiveness of the vaccine. He previously demonstrated several approaches including creating new boosters for targeting the variant, Like the one developed by Moderna Against the South African strain, or simply adding a batch of the existing vaccine to increase the antibody titer against the wild type of virus.